These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 30344297)

  • 1. The Pre-Transplant Drop in Panel-Reactive Antibodies Titer Evaluated Using Complement-Dependent Cytotoxicity (PRA-CDC) and the Risk of Early Acute Rejection in Sensitized Kidney Transplant Recipients.
    Kolonko A; Bzoma B; Giza P; Styrc B; Sobolewski M; Chudek J; Dębska-Ślizień A; Więcek A
    Medicina (Kaunas); 2018 Sep; 54(5):. PubMed ID: 30344297
    [No Abstract]   [Full Text] [Related]  

  • 2. Sensitization and sensitivity: defining the unsensitized patient.
    Gebel HM; Bray RA
    Transplantation; 2000 Apr; 69(7):1370-4. PubMed ID: 10798756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flow cytometry crossmatching as a predictor of acute rejection in sensitized recipients of cadaveric renal transplants.
    O'Rourke RW; Osorio RW; Freise CE; Lou CD; Garovoy MR; Bacchetti P; Ascher NL; Melzer JS; Roberts JP; Stock PG
    Clin Transplant; 2000 Apr; 14(2):167-73. PubMed ID: 10770424
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach.
    Poli F; Cardillo M; Scalamogna M
    Hum Immunol; 2009 Aug; 70(8):631-5. PubMed ID: 19527758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Harmful effect of preformed anti-MICA antibodies on renal allograft evolution in early posttransplantation period.
    Sánchez-Zapardiel E; Castro-Panete MJ; Castillo-Rama M; Morales P; Lora-Pablos D; Valero-Hervás D; Ruiz-García R; Apaza J; Talayero P; Andrés A; Morales JM; Paz-Artal E
    Transplantation; 2013 Jul; 96(1):70-8. PubMed ID: 23624543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Excellent renal allograft survival in donor-specific antibody positive transplant patients-role of intravenous immunoglobulin and rabbit antithymocyte globulin.
    Mai ML; Ahsan N; Wadei HM; Genco PV; Geiger XJ; Willingham DL; Taner CB; Hewitt WR; Grewal HP; Nguyen JH; Hughes CB; Gonwa TA
    Transplantation; 2009 Jan; 87(2):227-32. PubMed ID: 19155977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outcome of Pretransplantation Therapeutic Plasma Exchange in Highly Sensitized Deceased-donor Kidney Transplant Recipients.
    Tipjaiaue P; Ingsathit A; Kantachuvesiri P; Rattanasiri S; Thammanichanond D; Mongkolsuk T; Arpornsujaritkun N; Sumethkul V; Kantachuvesiri S
    Transplant Proc; 2017; 49(6):1249-1255. PubMed ID: 28735989
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Algorithm to manage highly sensitized kidney transplant recipients in Poland.
    Zielińska H; Moszkowska G; Zieliński M; Debska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2011 Oct; 43(8):2903-7. PubMed ID: 21996185
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of donor-specific antibodies using HLA-coated microspheres: another tool for kidney transplant risk stratification.
    Gibney EM; Cagle LR; Freed B; Warnell SE; Chan L; Wiseman AC
    Nephrol Dial Transplant; 2006 Sep; 21(9):2625-9. PubMed ID: 16644776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-transplant donor specific antibody and its clinical significance in kidney transplantation.
    Thammanichanond D; Ingsathit A; Mongkolsuk T; Rattanasiri S; Kantachuvesiri S; Sakhonrat C; Leenanupan C; Worawichawongs S; Kitpoka P
    Asian Pac J Allergy Immunol; 2012 Mar; 30(1):48-54. PubMed ID: 22523907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Probability of deceased donor kidney transplantation based on % PRA.
    Bostock IC; Alberú J; Arvizu A; Hernández-Mendez EA; De-Santiago A; González-Tableros N; López M; Castelán N; Contreras AG; Morales-Buenrostro LE; Gabilondo B; Vilatobá M
    Transpl Immunol; 2013 Jun; 28(4):154-8. PubMed ID: 23684945
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Current trend of induction and maintenance treatment in positive panel-reactive antibody patients: a report on OPTN/UNOS kidney transplant registry data.
    Cai J; Terasaki PI
    Chin Med J (Engl); 2011 Mar; 124(5):649-54. PubMed ID: 21518552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of panel-reactive antibody positivity on graft rejection before or after kidney transplantation.
    Lee KW; Kim SJ; Lee DS; Lee HH; Joh JW; Lee SK; Oh HY; Kim DJ; Kim YG; Huh WS; Oh WI; Lee BB
    Transplant Proc; 2004 Sep; 36(7):2009-10. PubMed ID: 15518726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Analysis of AHG-PRA and ELISA-PRA in kidney transplant patients with acute rejection episodes.
    Kaufman A; de Souza Pontes LF; Queiroz Marques MT; Sampaio JC; de Moraes Sobrino Porto LC; de Moraes Souza ER
    Transpl Immunol; 2003; 11(2):175-8. PubMed ID: 12799201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deceased donor kidney transplantation across donor-specific antibody barriers: predictors of antibody-mediated rejection.
    Schwaiger E; Eskandary F; Kozakowski N; Bond G; Kikić Ž; Yoo D; Rasoul-Rockenschaub S; Oberbauer R; Böhmig GA
    Nephrol Dial Transplant; 2016 Aug; 31(8):1342-51. PubMed ID: 27190362
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dynamics of anti-human leukocyte antigen antibodies after renal transplantation and their impact on graft outcome.
    de Souza PS; David-Neto E; Panajotopolous N; Agena F; Rodrigues H; Ronda C; David DR; Kalil J; Nahas WC; de Castro MC
    Clin Transplant; 2014 Nov; 28(11):1234-43. PubMed ID: 25142061
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-transplant panel reactive antibody in lung transplant recipients is associated with significantly worse post-transplant survival in a multicenter study.
    Hadjiliadis D; Chaparro C; Reinsmoen NL; Gutierrez C; Singer LG; Steele MP; Waddell TK; Davis RD; Hutcheon MA; Palmer SM; Keshavjee S
    J Heart Lung Transplant; 2005 Jul; 24(7 Suppl):S249-54. PubMed ID: 15993781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lifetime versus a graft life approach redefines the importance of HLA matching in kidney transplant patients.
    Meier-Kriesche HU; Scornik JC; Susskind B; Rehman S; Schold JD
    Transplantation; 2009 Jul; 88(1):23-9. PubMed ID: 19584676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric detection of HLA-specific antibodies as a predictor of heart allograft rejection.
    Tambur AR; Bray RA; Takemoto SK; Mancini M; Costanzo MR; Kobashigawa JA; D'Amico CL; Kanter KR; Berg A; Vega JD; Smith AL; Roggero AL; Ortegel JW; Wilmoth-Hosey L; Cecka JM; Gebel HM
    Transplantation; 2000 Oct; 70(7):1055-9. PubMed ID: 11045642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.